InvestorsHub Logo
Followers 86
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

Re: biopharm post# 271050

Sunday, 08/28/2016 12:45:04 PM

Sunday, August 28, 2016 12:45:04 PM

Post# of 345694
Foundation Medicine(owned by Roche) partners with AstraZeneca
https://www.genomeweb.com/molecular-diagnostics/foundation-medicine-partners-astrazeneca-launches-liquid-biopsy-test-acquires

... Looks like everyone should soon be wanting the best blood tests for early cancer detection... and where will Peregrine fall and rise in all these puzzle pieces

The soon to be announced trials ( likely because FDA soon to be approved biomarkers ) will be the surrogate endpoints to replace overall survival ....

Let's go CALICO ... I mean AstraZeneca... or ?????

Time is running out

"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline."
-- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News